ClinicaliQ Trial Snapshot
- Prevail Global Study — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT06535854.
- What is being tested: The Prevail Global Study evaluates the clinical safety and efficacy of the Prevail Drug-Coated Balloon (DCB), a therapeutic device designed to deliver medication directly to affected vascular tissue during percutaneous intervention.
- Patient eligibility overview: The study enrolls patients with coronary or peripheral vascular disease requiring percutaneous intervention, with specific inclusion/exclusion criteria determined by lesion characteristics, vessel anatomy, and clinical presentation (detailed eligibility criteria available in full protocol).
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
Eligibility Snapshot
- : * ≥ 18 years * Negative pregnancy test * Stable or unstable angina, positive functional test, or stable NSTEMI * Life expectancy >1 year * Willing and able to cooperate with study procedures and required follow up evaluations
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.